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Summary: This article describes the synthesis of a pure cortisol-3-(0-carboxymethyl) oxime with its subsequent use 
in producing highly specific antibodies and a 1 2 5I-tracer with a shelf life in excess of several weeks. 
An assay was developed using a pH of 4, thus allowing a direct measurement of Cortisol in serum without extraction 
or heat denaturation. 
The quality-control parameters were checked - the intra-assay C. V. in the working range (area of clinical interest) 
was under 5%, and the interassay C. V. under 11%. Correlation studies with results using other antisera and with 
3H-tracer are highly significant with the slope of the regression curve deviating less than 2% from the ideal volume. 
Finally the assay is fully automatable and is suitable for most automatic pipetting and analysis systems. 
Die Entwicklung eines direkten homologen Radioimmunoassays für Serum-Cortisol 
Zusammenfassung: Diese Arbeit beschreibt die Herstellung eines reinen Cortisol-3-(0-carboxymethyl) oxims und 
seine weitere Verwendung zur Gewinnung hochspezifischer Antiseren und eines 125I-Tracers mit einer Einsatzmög-
lichkeit von mehreren Wochen. 
Es wurde ein Assay entwickelt, der bei pH = 4 arbeitet. Dies erlaubt die direkte Bestimmung von Serum-Cortisol 
ohne Extraktion oder Hitzedenaturierung. 
Als Qualitätskontrollgrößen fanden sich ein Intraassay-Variationskoeffizient im steilen Bereich der Standardkurve, 
der für klinische Fragestellungen wichtig ist, von unter 5%, und ein Interassay-Variationskoeffizient von unter 11 %. 
Die Korrelationsstudien mit Ergebnissen, die man mit anderen Antiseren bzw. mit einem 3H-Tracer erhielt, waren 
alle hochsignifikant mit einer Abweichung der Regressionsgeraden von weniger als 2%. Der Assay ist voll automati-
sierbar und für die meisten automatischen Pipettier- und Analysensysteme adaptierbar. 
Introduction 
As the request for the routine measurement of the 
Cortisol concentration in serum grows, so does the need 
for a simple and accurate method with high capacity. 
The method of choice is an immunoassay. 
Because of its low molecular weight, Cortisol does not 
have any intrinsic antigenic properties (1) and must 
therefore be coupled to a carrier protein to form a 
complex capable of producing an antibody response. 
Because of the large number of naturally occurring 
1 ) Supported by the Deutsche Forschungsgemeinschaft 
(SFB 51) 
2 ) Preliminary results were presented in part at the "Biochemi-
sche Analytik' 1, München 1978 and 1980. 
0340-076X/81/0019-0427S02.00 
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steroids, many of which are similar in structure to 
Cortisol, a specific assay is needed which will measure 
Cortisol alone in serum. This makes the synthesis of 
pure specific defined derivatives of the utmost impor-
tance. 
Another important point is the choice of isotope for the 
radioactive labelling. Because of the lower costs, higher 
specific activity and counting efficiency, not to mention 
the relative case of aqueous waste disposal, a 1 2 5 iodine-
tracer is the label of choice. 
Finally, in order to achieve a high throughput of samples, 
an extractive or heat denaturation step to free Cortisol 
from Cortisol binding globulin must be avoided in order 
to allow automation of the method. 
These problems have been dealt with individually in the 
construction of the assay described here. 
Materials and Methodology 
All chemicals were of "pro-analysi" grade or "puriss" grade. 
The following chemicals were purchased from Merck (Darm-
stadt): 
Cortisol, all reagents for buffer preparation, all reagents used 
as solvents, molecular sieve (0.4 nm), Silica Thin Layer 
Chromatography plates, Tyramine hydrochloride, Tyrosine-
methyl-ester hydrochloride, Chloramine-T, Sodium metabi-
sulphite, Potassium bromide, Polyethylene glycol 6000, 
N-ethyl-N(3-dimethylaminopropyl) carbodiimide hydrochloride. 
Human serum albumin, ß-, 7-globulin and thyroglobulin were 
purchased from Sigma Chemical Co. (Taufkirchen) 
Rabbit-7-Globulin was purchased from Serva (Heidelberg) 
Carboxymethoxylamine hemihydrochloride was purchased from 
EGA-Chemie (Frankfurt/Main) 
Pertussis vaccine and Freund''s Complete Adjuvant were 
obtained from Behringwerke (Marburg/Lahn) 
Sodium1 2 5iodide was obtained from Amersham-Buchler (Braun-
schweig) 
Cortisone was obtained from Schering (Berlin) 
Fludrocortisone and Triamcinolone were purchased from van 
Heyden (Munich) 
Betamethasone was obtained from Byk-Essex (Munich) 
Methylprednisolone was obtained from Homburg (Frankfurt/ 
Main) 
Spironolactone was obtained from Boehringer (Mannheim) 
AH other steroids were purchased from Fluka (Neu-Ulm) 
Synthesis of a pure cortisol-3-(0-carboxymethyl)oxime 
The principle of the reaction between Cortisol and carboxy-
methoxylamine hemihydrochloride is the conversion of the 
ketogroups at position C3 and C20 to an oxime group, whose 
carboxyl group is then available for coupling reactions as used 
in the production of immunogen and tracer. Three reaction 
products are formed, namely a C3-oxime, a C2o-oxime and a 
C3-2o~dioxime. The following method describes the production 
of a pure C3-oxime. 
The following reagents are added to a Quickfit-flask: 1 mmol 
Cortisol (362.5 mg) dissolved in 1 ml dry pyridine, followed by 
0.5 mmol carboxymethoxylamine hemihydrochloride (109 mg) 
dissolved in 1 ml dry pyridine. 
An excess of a molecular sieve (0.4 nm) to remove the water 
formed in the reaction was added and the flask connected to 
a desiccator-U-tube filled with silica gel and left to react at 
room temperature. 
The reaction was monitored by removing a small volume of the 
reaction mixture at regular intervals, transferring it to a thin-
layer plate (0.2 mm silica gel) and running it in an ethyl acetate, 
acetic acid, water (9 + 1 + 0.1 by volume) mixture. Ultraviolet 
light (254 nm) was used to visualise the spots. As time pro-
gressed, the spot given by Cortisol disappeared, while at the same 
time a new, more polar spot appeared. The reaction time for 
the complete disappearance of Cortisol was about 6 hours. 
Figure 1 shows the reaction "catalysed" by pyridine. 
The pyridine was removed from the reaction products by using 
rotary vacuum distillation and the product dissolved in acidified 
(acetic acid) dioxane. The dioxane was then removed in a similar 
fashion. The latter process was repeated until no more pyridine 
could be detected by thin-layer chromatography in ultraviolet 
light. 
The product so obtained consisted mainly of cortisol-3-(0-carb-
oxymethyl)oxime with traces of cortisol-20-(O-carboxymethyl) 
oxime and C-3,20-di(O-carboxymethyl)oxime together with 
unchanged Cortisol. This mixture was dissolved in 1 ml acidified 
(acetic acid) dioxane and transferred to a preparative silica gel 
thin-layer chromatography plate (2 mm) using the same solvent 
system as above. 
Each plate could accommodate ca. 0.1 mmol mixture. After the 
plates had been run, they were dried and the bands marked 
under ultraviolet light. It is known from infra-red spectroscopy 
that the cortisol-3-(0-carboxymethyl)oxime derivate followed 
the unchanged Cortisol. The cortisol-3-(0-carboxymethyl)oxime 
was scratched from the plate and dissolved from the silica gel 
by alternate washing with dioxane and solvent mixture, keeping 
the silica gel in place on a glass sinter and allowing the solvents to 
flow over it. After removal of the solvent, the product was dried 
over P2O5 in oil-vacuum. 
The yield was between 60 and 70% of the theoretical value. The 
cortisol-3-(0-carboxymethyl)oxime was kept dry and stored at 
- 2 0 ° C . 
Antigen synthesis 
Due to favourable experience using bovine thyroglobulin as a 
hapten carrier for raising antisera to low molecular weight 
peptides (2), this protein was chosen as the vehicle for coupling 
to Cortisol-3-(0-carboxymethyl)oxime. Two coupling methods 
were used, namely a carbodiimide (3) and a mixed anhydride 
reaction (4), to study the molar incorporation and antigenity 
of the synthesized conjugates. 
Carbodiimide method 
10 jumol cortisol-3-(0-carboxymethy l)oxime (4.4 mg) were 
dissolved in 1 ml dioxane to which 1 ml acidified water (pH 5.5) 
was slowly added dropwise. 60 mg N-ethyl-carbodiimide hydro-
0 - C H 2 - C 
, N 0 H 
Fig. 1. Pyridine-catalysis of cortisol-3-(0-carboxymethyl)oxime 
reaction. Only the A-ring and 3-position of the cortisol-
molecule is shown. 
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chloride was added as dry substance and 0.1 jumol bovine thyro-
globulin subunit (16 mg) in 1 ml acidified water (pH = 5.5) 
slowly added. The reaction was allowed to proceed at room 
temperature for 20 hours. During the first hour, the pH was 
kept at 5.5. After termination of the reaction, 3 ml 1 mol/1 
hydroxylamine hydrochloride solution was added to destroy 
any excess of carbodiimide. The mixture was allowed to stand 
one hour, and was then dialysed first against 0.01 mol/1 NaOH 
to remove uncoupled cortisol-3-(0-carboxymethyl)oxime, then 
against distilled water overnight. The product was lyophilised 
and stored at - 20 °C until required. 
Mixed anhydride reaction 
Here, 0.1 Mmol bovine thyroglobulin subunit (16 mg) was 
dissolved in 1 ml saturated NaHC03-solution, pH = 8.5. 10 jumol 
cortisol-3-(0-carboxymethyl)oxime (4.4 mg) dissolved in 1 ml 
dioxane were mixed with 20 jumol triethylamine (2 mg) and 
cooled to 5 °C; then 11 jumol «obutylchloroformate (1.5 mg) 
were added and stirred for 20 min at 5 °C, to form the mixed 
anhydride. The cooled bovine thyroglobulin solution is added 
dropwise over 30 minutes and the reaction mixture allowed to 
stand at room temperature overnight. Removal of unreacted 
small molecules was carried out by dialysis as described above. 
Antibody production 
Ten rabbits of no fixed race or sex, aged 3 months were used. 
After 20 weeks, 7 had either died or had been bled out. The 
remaining 3 were boostered together with 3 new rabbits over a 
further 9 month period. 
The lyophilised antigen was dissolved in physiological saline so 
that each animal received 0.016 Mmol coupled bovine thyro-
globulin subunit in 0.25 ml. An equal volume of complete 
Freund's adjuvant was used to form a water in oil emulsion 
which was injected intradermally in 30-40 sites on the flanks 
and along the spine. The booster scheme and antibody-titer-
curves are shown in figure 6. With the first two injections, each 
rabbit received 0.25 ml Pertussis vaccine as additional stimulus 
(2). Ten to fourteen days after the third and subsequent injec-
tions, blood was taken from an ear vein and tested for antibodies 
as follows: The sera were diluted with phosphate buffer and 
100 M! portions incubated for 75 min with 100 M1 tracer. 50 fil 
carrier serum and 1000 p\ 125 g/1 or 150 g/1 polyethylene-
giycol were used to separate bound and free tracer (5). Titer 
was defined as the serum dilution which bound 50% of the 
added tracer under assay conditions. 
Production of a 1 2 5 1-cor t i so l tracer 
The so-called 2-step method of tracer production is preferred. 
As Cortisol is not easily directly iodinated, an easily iodinatable 
molecule is first reacted with the cortisol-3-(0-carboxymethyl) 
oxime, then labelled in a second step. 
In view of the disadvantages of the carbodiimide reaction, a 
mixed anhydride method was used to couple either tyrosine-
methyl-ester or tyramine to cortisol-3-(0-carboxymethyl)oxime 
in a molar ratio of 2:1. The reactants are dissolved in dry 
pyridine and the reaction carried out as described above. After 
completion of the reaction, the products are freed from solvent 
and the remaining substance dissolved in ethyl acetate and 
washed with 0.01 mol/1 NaOH and 0.01 mol/1 HCl. After removal 
of the ethyl acetate under vacuum distillation, the dry powder, 
either cortisol-3-(0-carboxymethyl)oxime-tyrosine methyl ester 
or -tyramine, was stored at - 20 °C until use. Before labelling, 
1 mg of derivate was dissolved in 1 ml dioxane, and 4 ml 
0.5 mol/1 phosphate buffer pH = 7.5 added dropwise. 
The labelling was carried out as follows: 
20 M! steroid derivative (ca. 4 Mg), 
20 M1 N a 1 2 5 I (2 mCi = 75 kBq) and 
20 M! Chloramine T (10 Mg) 
were added to a siliconised plastic tube and allowed to react 
for 2 min, when the reaction is stopped by addition of 40 M1 
N a 2 S 2 0 5 (80 Mg). 
A pre-purification step is carried out as published (6). 100 M! 
distilled water and 200 ß\ ethyl acetate are added to the reac-
tion tube and shaken; the organic phase is then transferred to 
a thin-layer chromatography plate. The aqueous phase is 
washed twice with ethyl acetate, and the organic phase trans-
ferred each time to the plate. The plate is then developed using 
the solvent system previously described (ethyl acetate: acetic 
acid: water - 9 + 1 + 0 . 1 by volume). After separation the 
plate is cut into thin strips and counted in a gamma counter. 
The strips with high radio-activity were eluted with ethyl 
acetate, the solvent then removed and the remaining substance 
dissolved in buffer ( 0 . 1 mol/1 citrate buffer, pH = 4 , containing 
2.5 g/l gelatin and 2 . 5 g/1 bovine serum albumin, both steroid 
free). Each fraction was tested for maximum binding (B 0 ) and 
unspecific binding ( N ) in antibody excess. The fractions with 
BQ > 9 0 % and N < 5 % were pooled. I f no fraction had these 
properties, the fractions with the highest binding were re-
extracted into ethyl acetate and rechromatographed. Useable 
tracer was diluted to a concentration of ca. 2 X 1 0 8 counts/ 
min • 1 (3.3 MBq/l) and stored at - 2 0 °C until use. 
Radioimmunoassay 
Cortisol-free serum 
All standards were made up in cortisol-free serum or in a pro-
tein solution containing human albumin, and ß and 7-globulins 
in physiological concentrations, in which each component had 
been tested for Cortisol content. Dexamethasone-suppressed 
patients donated serum which was read off a buffer curve. Those 
patient sera showing no detectable Cortisol were pooled and 
used. The "synthetic serum'* was only used as an emergency 
measure, or in experimental situations. Standard curves made 
up in hormone-free serum and in the protein solution were 
identical. 
Tracer-binding kinetics 
The tracer binding of the antiserum K 9 for the zero and 
1 5 Mg/dl ( 4 1 4 nmol • liter" 1) standard at room temperature 
shows a plateau after one hour. As the assay was almost in 
equilibrium, an assay time of 7 5 minutes was chosen. The results 
with 4 °C incubation were similar, but with lower binding. 
pH 4-assay 
The maximum affinity of Cortisol binding globulin (CBG) for 
Cortisol is seen at about pH 8. Under both acid and alkaline 
conditions, the affinity of CBG falls off rapidly, and at pH 4 , 
CBG has no measurable affinity for Cortisol ( 7 ) . 
Figure 2 shows the pH-dependance of the Cortisol binding to the 
antibody K 9 . At pH 4 the affinity of the antibody is maximal, 
thus allowing an assay to be developed without prior denatura-
tion of CBG, an advantage in the question of automation. 
Albumin, as well as CBG, binds Cortisol (8) and so the effect of 
albumin upon the accuracy of the assay at pH 4 was tested. As 
only 3 M1 serum was used in the assay (see below) amounting to 










- i . j . — - 4 N 
I . 
PH 
Fig. 2. pH-dependence of the antiserum K9 with maximal 
binding (B 0 ) and unspecific binding (N). 
J. Clin. Chem. Clin. Biochem. / VoL 19, 1981 / No. 7 
430 Stalla, Giesemann, Müller, Wood and Scriba: A direct homologous radioimmunoassay for serum Cortisol 
with that in the tracer (250 Mg/100 MD, concentrations of 
10-160 g/liter (1000-16000 Mg/sample) were tested. There 
was no significant change in the binding of tracer to the anti-
body at pH 4. 
Affinity studies 
The affinity of the antisera was tested under assay conditions 
with the help of a Scatchard plot (see below), which after trans-
formation of the standard curve data allows the affinity con-
stant of the antibody for the antigen to be calculated. Figure 3 
shows the Scatchard plot for antibody K9 and gives an affinity 
constantof0.il X 10 1 0 1/mol. 
Optimised double antibody technique 
A technique using combined second antibody (2. Ab) and poly-
ethylene glycol in low concentrations has been developed in 
this laboratory (9) for peptide hormones; it accelerates the 
formation of precipitable l .Ab-2.Ab complexes, which can 
either be centrifuged or filtered to effect a bound/free separa-
tion. The application of this method to the cortisol-RIA leads 
to a time saving of 50%, as well as an elevation of B 0 , and 
reduction of N when the 2.Ab polyethylene glycol solution is 
added in 0.07 mol/1 phosphate buffer pH 7.4. 
K Q=0.11*10 1 U l/mol 
0 0.09 0.19 0.28 0.37 0A7 0.56 0.66 075 0.84 Q94 
Bound (labelled and unlobelledlontigen [nmol/ll 
Fig. 3. Scatchard plot under assay conditions showing affinity 
Automation 
The assay, as shown in table 1, lends itself for use in the auto-
matic system developed in this department (10). Details of this 
automation have already been published (11). In brief, the 
capacity of the system is limited by the dilutor which can 
process 170-250 samples/hour with a coefficient of variation 
of < 1% for this assay. 
Data processing 
Figure 4 shows a typical standard curve using data for the auto-
mated assay for Cortisol, and a spline-function (12). The curve 
form was characterised by use of the 50% intercept and the 
precision by the lower limit of detection. 
Results 
Synthesis 
of a pure cortisol-3-(0-carboxymethyl)oxime 
Figure 5 shows an IR-spectrogramme of Cortisol, testo-
sterone and cortisol-3-(0-carboxymethyl)oxime. The 
arrows show the carbonyl groups at ca. 1710 cm"1 and 
ca. 1640 cm"1 in Cortisol and only at 1640 cm"1 in 
testosterone which only has a C3-keto group. In the 
case of cortisol-3-(0-carboxymethyl)oxime, the band at 
1710 cm"1 due to the C 2 0-keto group is fully intact, 
whereas that at 1640 cm"1 has disappeared, showing a 
specific conversion of the C3-keto group. 
The keto group at C 3 appears to be more reactive, as the 
keto group at C 2 0 is sterically hindered by the C n > 2 1 -
hydroxymethyl groups. This reaction rate difference is 
not seen at higher temperatures. 
The effect of temperature on the rate and specificity of 
the reaction was studied at (a) 50-60 °C, (b) 10-15 °C 
and (c) room temperature (20-22 °C). In the case of 
(a) above, the reaction was complete within 60 min, but 
the specificity was poor, equimolar amounts of C 3 - and 
C2o-derivatives being seen, together with unidentifiable 
Tab. 1. Assay details. 
Standard solution or serum 
[ 1 2 5 I lcort isol tracer 
in 0.1 mol/1 Na-citrate-buffer pH=4 
+ 2.5 g/1 gelatin + 2.5 g/1 bovine serum albumin 
(ca. 10000 counts/min • 150 
Cortisol-antiserum 
(1:8000 in 0.1 mol/1 Na-citrate buffer pH=4) 
75 min incubation at room temperature 
400 M1 second antibody (lot-dependent) 
for each one hundred samples 
in 50 ml 60 g/1 polyethylene glycol 
in 0.06 mol/1 Na-phosphate buffer pH=7.4 
+ rabbit-7-globulin (7 Mg/sample) 
60 min incubation at room temperature 
Separation using filtration or centrifugation 
(10 min at 3000 £) 












7.8 15J8 31.2 62.5 125 
Cortisol [ j i g / l l 
250 500 1000 
Fig. 4. Typical standard curve using antiserum K9, own 
(125I]cortisol-3-(0-carboxymethyl)oxime-tyrosine-
methyl-ester tracer and second antibody/polyethylene 
gly col-separation. 
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Wave number [cm" 1) 
Fig. 5. Infrared-spectra showing absorption bands of the C20- a n d C3-keto groups. Above: Cortisol, middle: testosterone, below: 
cortisol-3-(0-carboxymethyl)oxime. 
side-products. At lower temperatures as in case (b), the 
reaction took two days and showed no better selectivity 
than at room temperature (case (c)), where the reaction 
was complete within 6 hours. 
Antigen synthesis 
The degree of coupling of cortisol-3-(0-carboxymethyl) 
oxime to the bovine thyroglobulin was determined by 
using [3H]cortisol-3-(0-carboxymethyl)oxime and meas-
uring the ratio of radioactivity in the starting material to 
that in the product. 
Specific coupling of cortisol-3-(0-carboxymethyl)oxime 
to bovine thyroglobulin subunit was 5:1 (mol/mol) and 
unspecific coupling 2:1 using the carbodiimide method, 
the corresponding figures for the mixed anhydride 
method being 20:1 and 2 :1 , respectively. 
A further disadvantage of the carbodiimide method is 
that it takes place at a slightly acid pH were the solubility 
of cortisol-3-(0-carboxymethyl)oxime is very low. It is 
possible that here, instead of a carboxyl group activation, 
a guanidine derivative is formed. It is also possible that 
the bovine thyroglobulin is partly polymerized and 
thereby denatured by carbodiimide reaction products 
(1). This is reflected by the poor water solubility of 
bovine thyroglobulin-cortisol-3-(0-carboxymethyl) oxime 
formed by the carbodiimide reaction. 
Ant ibody production 
Figure 6 shows the antibody titer curve over 42 weeks 
for a rabbit injected with the cortisol-3-(0-carboxy-
methyl)oxime complex formed by the carbodiimide 
reaction. Because of the low titer, all rabbits were 
boostered with the cortisol-3-(0-carboxymethyl)oxime 
complex formed by the mixed anhydride method. After 
a single injection the titer rose from 1:3200 to 1:16000 
(K2). The Cortisol content of the antiserum at the con-
centration used in the assay was tested after pepsin-HCl 
digestion to destroy the antibody. The value lay under 
the detection limit of the assay and therefore proved to 
be unimportant. 
Production of a [ 1 2 5 IJcortisol tracer 
In the radioimmunoassay in current use in this laboratory 
(see below) a 50% intercept of 10 jug/dl (276 nmol • 
liter" 1) and less was achieved using the 1 2 51-cortisol-
(0-carboxymethyl)oxime-tyrosine-methyl-ester derivative 
and a 50% intercept of 50 Mg/dl (1380 nmol • liter" 1) 
for the [125I]cortisol-(0-carboxymethyl)oxime-tyramine 
J. Clin. Chem. Clin. Biochem. / VoL 19, 1981 / No. 7 
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M I I ' I M M l M l I I I 
K 1-10: 0 10 20 30 4 0 5 0 6 0 ^ 
K 13.14,16: 0 2 12 22 32 ^ 
Weeks a f te r f i r s t immunization 
Fig. 6. Antibody-titer from rabbits injected with cortisol-3-(0-carboxymethyl)oxime-thyroglobulin-conjugates. 
+ = rabbits died. From week 0-28 K1-K10 received a conjugate cortisol-3-(0-carboxymethyl)oxime: bovine thyroglobulin 
subunit = 4 : 1 , from the 28th week a conjugate cortisol-3-(Ocarboxymethyl)oxime: bovine thyroglobulin subunit =6:1 
using carbodiimide reaction. Rabbits 13, 14, 16 received only the latter conjugate (week 28 = 0). From week 16 K 13, 14, 16 
and from week 44 K 1, 2, 9 received a conjugate cortisol-3-(0-carboxymethyl)oxime: bovine thyroglobulin subunit = 20:1 
using the mixed anhydride method. 
derivative. The tyrosine-methyl-ester derivative was 
introduced for reasons of sensitivity. This difference in 
the form of the standard curve with these derivatives 
agrees with already published data (6). The shelf-life of 
the tracer is at least several weeks, thus making labelling 
necessary about 6 times a year. 
Radioimmunoassay 
Correlation studies 
The performance of antiserum K9 was compared with 
the antiserum in current use in the laboratory, which 
had been donated by Professor ZT. Kuss ( I . Frauenklinik 
der Universität München). The correlation was studied 
in 50 routine sera measured with both antisera on the 
same day using identical reagents. The regression data 
for the line y = a + bx where y represents the K9 values 
and x the "control-method", was excellent with 
a = 3.4jug/l and slope b = 0.99. The correlation coeffi-
cient (r) was 0.94 and gave a p-value of < 0.001, i.e. 
highly significant. 
A correlation with the 1 2 5I-tracer using the antiserum 
donated by Kuss and pH=4-assay compared with the 
earlier 3H-assay with extraction and column chromato-
graphy separation of bound and free antigen (13) gave 
a correlation coefficient for 43 data pairs of r = 0.87 
and for the regression line a = 10.6 jug/1 and b = 0.971. 
Again the correlation was highly significant. These results 
show that the new assay with antiserum K9 gives the 
same results as the antiserum donated by Kuss using 1 2 5 1 
or 3 H (an indirect, but logically grounded assumption). 
Specificity 
Figure 7 shows the cross-reaction profile of both other 
steroids using antiserum K9. The cross-reaction of 
Cortisol is set at 100% and the cross-reaction of the 
steroids is by weight (mean of several concentrations). 
As a comparison, the antiserum donated by Kuss cross-
reacted with cortisone to an extent of 85%, 11-deoxy-
cortisol 30% and prednisolone 35%. 
Quality control 
The following results were obtained using the described 
assay procedure partly with antiserum K9 and partly 
with antiserum donated by Kuss. 
The intra-assay and inter-assay coefficients of variation 
(C.V.) were tested. The intra-assay C.V. for 5 sera 
reflects the parabolic form of a precision profile with 
high C.V. at low and high concentrations, i.e. where the 
standard curve is flattest (11). 
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Reactivity 
m i i i I H I Cortisol 
1 0.4 Cortisone 
• 3.5 Corticosterone 1 < 0.01 11-Deoxycorticosterone 
• 3.4 Progesterone I < 0.01 11-Hydroxyprogesterone 
1 < 0.01 Oestradiol 
1 < 0.01 Oestrone 
1 < 0.01 Oestriol 
1 < 0.01 Androstendione 
1 1.4 Pregnenolone 
1 1.2 Testosterone 
1 1.0 Prednisolone 
• • 1 12.3 Prednisone 
• • • 18.0 Methy lprednisolone 1 0.6 Dexamethasone 
I < 0.01 Betamethasone 
8.0 Fluorocortisone 
1 1.5 Fluorocortolone 
1 0.3 Triamcinolone 
1 < 0.01 Spironolactone 
I < 0.01 Carbenoxolone 
Fig. 7. Shows cross-reactivity of antiserum K9 with several 
naturally occurring and synthetic steroids. 
The inter-assay C. V. for 33 consecutive assays at a level 
of 174 ;ug/l (480 nmol • liter" 1) was 10.5%. The mean 
recovery of added Cortisol to a patient serum in the 
range of 10-500 jug/l (28-1380 nmol • liter" 1) was 
95 ± 7.2% for 15 different concentrations. 
Normal range 
Due to the circadiurnal rhythm of serum Cortisol levels, 
all blood was taken at 9 a.m. under fasting conditions. 
The normal range for 30 patients lay between 55 and 
215 ptg/1 (151-593 nmol • liter"1) with a mean and 
standard deviation of 143 ± 55 jug/1. The distribution of 
these 30 sera shows a non-Gawssw«-distribution. To 
prove the distribution type at least 100 sera must be 
measured. 
Discussion 
Being unsuccessful in repeating published methods for 
the production of "pure" cortisol-3-(0-carboxymethyl) 
oxime, and because of the obscure criteria for deter-
mining structure and purity (14, 15, 16), a new start 
was made (17). By optimising the synthesis in the 
absence of water and under pyridine catalysis, together 
with careful choice of the chromatographic solvent, it 
was possible to prepare a cortisol-3-(0-carboxymethyl) 
oxime of satisfactory purity in thin-layer chromato-
graphy, with a yield of about 70% of the theoretical. 
Infra-red spectroscopy showed that only the C-3-isomer 
of cortisol-(0-carboxymethyl)oxime was produced 
(fig. 5). This coupling-method can be used with minor 
modifications for all steroids with a C3-keto group and 
a non-aromatic A-ring. For testosterone, for example, 
with only a C3-keto group, the synthesis is much easier 
than for Cortisol. 
Further attempts to produce a direct cortisol-3-tyrosine 
derivative by reductive amination (Leuckart-Wallach) 
met with no success. The use of sodium cyanoborhydride 
(NaBH 3CN) as a specific reductant for azomethines (18) 
in the presence of H + was only successful for the reduc-
tion of cortisol-3-(0-carboxymethyl)oxime. 
The use of the mixed anhydride method for coupling 
cortisol-3-(0-carboxymethy 1)oxime to bovine thyro-
globulin is, because of the alkaline conditions, to be 
prefered for steroid conjugation; the acid solutions 
needed for the carbodiimide conjugation create solubility 
problems. This was plainly seen in the boostering of 
rabbits with the mixed anhydride product in rabbit K9 
which led to an immediate 5-fold increase in the anti-
serum titer. It is well known that there is a minimum 
ratio of hapten to carrier, below which no or only a 
poor antibody response is obtained (19). For steroids, 
a mixed anhydride reaction combines an optimum pH/ 
protein solubility conditions with the maximum incor-
poration. 
That the tracer is stable for at least two months means 
that the somewhat complicated methodology must be 
carried out at the most 6 times a year, or when larger 
amounts of tracer can be made, even less frequently. 
Although a two-phase system was used in the labelling, 
it should be possible to carry out the labelling in an 
organic phase using a soluble iodination agent such as 
Iodogen® (20), an alternative would be labelling of the 
tyrosine-methyl-ester with subsequent coupling to the 
cortisol-3-(0-carboxymethyl)oxime using the mixed-
anhydride method under water-free conditions. This 
would be less harsh as no oxidation agent would come 
into contact with the cortisol-3-(0-carboxymethyl) 
oxime. The disadvantage is the longer reaction time 
(about 14 hours), in which radiolysis could give rise to 
more damage than the Chloramine-T or Iodogen. 
The attempt to simplify the purification of tracer, by 
using Sephadex LH-20 gave no satisfactory results. 
No figure for the specific activity of the tracer could be 
given, because of the uncertainty of the recovery through 
the many purification steps. 
The use of a pH=4-assay (11) allowed full automation 
wifh a precision in the steep-part of the standard curve 
of under 5% as measured by the intra-assay C.V. 
The antiserum K9, produced with the pure cortisol-3-
(O-carboxymethyl)oxime-bovine thyroglobulin con-
jugate, showed excellent specificity, and gave rise to a 
sensitive, precise, accurate and rapid assay. This assay 
could be run using either standards in cortisol-free serum 
or in a carefully prepared "synthetic serum" to give the 
same results as the assays previously in use in the labora-
tory. This antiserum with its lower cross-reactivity to 
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other steroids has potential advantages, especially in 
certain scientific problems. 
The development of a direct and homologous assay for 
serum Cortisol has led to a time and work-saving of 
above 75% in comparison with the original 3H-method 
with extraction and column chromatography (13). 
These points are very important, especially in a labora-
tory rationalisation programme, where a simple, short 
assay is preferable to a long and complicated one. 
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In the paper by Bauer, K., this J. 19, 971-976 (1981) the com-
position of the reagent in the section "Materials and Methods" 
should read from line 3: " . . . and reagent (0.8 mol/1 potassium 
phosphate buffer pH 7.2; 2 mol/1 methanol, 1.9 mmol/1 4-amino-
phenazone and 8 g/1 hydroxypolyethoxydodecane) were taken 
from a cholesterol test kit . . .". The concentration of hydroxy-
polyethoxydodecane was erroneously given as 80 g/1. 
The sense of the abstract by Mallet, E. et al. (1981) 
this J. 79 760-761 was distorted by an erroneous 
correction. The abstract should read: 
Mallet, E., J.~P. Basuyau, Ph. Brunelle and C.-H. de 
Menibus 
Immunoreactive C-Peptide from Proinsulin in Am-
niotic Fluid of Diabetic Pregnant Women as a Pre-
dictive Risk Factor of Hypoglycaemia in Infants of 
Diabetic Mothers 
Groupe de Biochimie Appliquee ä I'Endocrinologie 
U.E.R. Medecine = Pharmacie, Rouen France 
Hypoglycaemia continues to be the major metabolic 
risk for the infants of diabetic mothers. The aim of 
this study is to look for correlations between hyper-
insulinism of infants of diabetic mothers, as evaluated 
by C-peptide/glucose ratio and the following factors: 
maternal glycosylated haemoglobin A , in the prenatal 
period, amniotic fluid C-peptide (when amniocentesis 
was performed at 36 weeks gestation to evaluate foe-
tal maturity) and finally the macrosomia index. C-
peptide was measured by radioimmunoassay using 
Mallinckrodt R kit . 
26 pregnant diabetic mothers on insulin therapy, 8 of 
whom had been submitted to amniocentesis, and their 
newborns were studied. Foetal hyperinsulinism (C-
peptide/glucose ratio: M ± o = 1.25 ± 1.15 nmol/1 
in diabetic women, normal range: 0.445 ± 0 . 1 8 , p 
< 0.005) and neonates hyperinsulinism (C-peptide/ 
glucose ratio: M ± o = 0.52 ± 0.10 in infants of dia-
betic mothers, normal range: 0.12 ± 0.01, p < 0.001) 
were verified. Infants of diabetic mothers hyperinsu-
linism on day 1, as expressed by C-peptide/glucose 
ratio, was correlated with the macrosomia index (r = 
0.62, p < 0 . 0 5 ) and with amniotic fluid C-peptide 
(r = 0.88, p < 0.001); however there was no signifi-
cant correlation with maternal glycohaemoglobin A | 
in the prenatal period. 
In conclusion, the macrosomia index and amniotic 
fluid C-peptide appeared to be predictive factors for 
infants of diabetic mothers hypoglycaemia, making 
possible an early calculation of the appropriate rate 
of glucose infusion at delivery. 
E. Mallet 
Centre Henri Becquerel 
Laboratoire de Biochimie 
F-76038 Rouen Cedex 
IX 
In the abstract by Desch, G. et al. (1981) this J. 79, 651 the last 
two sentences should read: "During dialysis without glucose in a 
patient with low plasma acetate (2.1 mmol/1) no incorporation of 
deuterated acetate into plasma total cholesterol could be meas-
ured, either during dialysis or 10 hours after, using mass frag-
ments Mr + 18 (Mr = molecular weight of derivatized cholesterol). 
In this case the whole deuterated cholesterol accounted for about 
10% of plasma total cholesterol at the end of dialysis and up to 
10 hours after." 
In the abstract by Frey, B. M . et al. (1981) this J. 79, 
671 
"Underestimation of Transcortin Concentration by 
Protein Binding Measurements" as a consequence of 
misunderstanding between the two institutions ana-
lyzing the transcortin concentrations by two different 
methods, the units used for the one method were in-
correctly converted into the units used for the other 
method. This was the origin of an erroneous con-
clusion. The abstract should read as follows: 
Frey, Brigitte M., N. Holford and F. J. Frey 
Esatimation of Transcortin Concentration by Protein 
Binding Measurements and Electroimmunodiffusion 
Medizinische Poliklinik der Universität Bern and Clin-
ical Pharmacology, University of California, San Fran-
cisco, CA 
Since the binding of prednisolone to plasma proteins 
occurs at transcortin and albumin, prednisolone ex-
hibits nonlinear kinetics in the therapeutic dose range. 
Therefore the concentrations of albumin and trans-
cortin are mandatory for the interpretation of predni-
solone kinetics in clinical studies. The concentrations 
of transcortin are usually obtained indirectly on the 
basis of in vitro binding studies. I t is unknown whether 
or not the concentrations of transcortin calculated on 
the basis of these binding studies provide the true 
concentrations of transcortin. In the present study we 
compare in 22 patients on chronic prednisolone treat-
ment the concentrations of transcortin obtained 
a) indirectly by equilibrium dialysis (ED) (1) and 
b) directly by electroimmunodiffusion (E ID) using a 
specific antibody for transcortin (gift from Dr. Van 
Baelen, Leuven). 
Prednisolone was measured by high performance l i -
quid chromatography (2). 
The mean concentrations of transcortin were, when 
assessed by E I D and by E D , 0.635 ± 0.175 [xmol/1 
and 0.670 ± 0.259 [xmol/1, respectively. Between the 
measurements of E I D and E D a linear relationship 
was found: [imol/1 (ED) = 0.859 | imol/ l (EID) + 0.125 
limol/1 ( P < 0 . 0 1 ) . 
Conclusion: Studies using E D to assess the concen-
tration of transcortin provide true concentrations of 
transcortin. 
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duodenum 
—, mucosa 
— , invertase 39 




- , enzyme activities 931 
- , fibroblasts 809 
— , glycosaminoglycans 809 
dyslipidaemia 
- , screening 615 
— , newborns 615 
efficiency test 173 
eicosapentaenoic acid 
—, atherosclerosis 721 
EKTACHEM 
- , albumin 841 
- , total protein 841 
elastase 
- , leukocytes 232 
— , enzyme immunoassay 
232 
elderly 
—, reference ranges 617 
electrobiography 769 
electrodes 
- , enzyme 861, 863 
— , creatine 861 
— , creatinine 861 
— , in vivo monitoring 863 
—, fluoride sensitive 838 
— , peroxide assay 838 
ion sensitive 49 
—, ion specific 804 
- - , slides 804 
- , skin surface 795 
— , blood gases 795 
electroimmunoassay 
- , apolipoproteins 872 
electrolyte 
- , analyzer 741 
electrolytes 
- , blood 882 
—, continuous monitoring 
860 
- , myocardium 606 
— , high altitude 606 
—, potentiometry 49 
- , serum 606 
— , high altitude 606 
electron spin resonance 
—, lipoproteins 707 
electrophoresis 
- , apolipoproteins 874 
- , cells 693 
- , fully automated 379 
— , serum 379 
- , history 491 
—, proteins 712 
— , serum 712 
- , thin layer agarose 648 
emergency analysis 
- , bilirubin 228 
emergency laboratory 
- , priority tests 783 
- , processing 783 
emergency service 842 
encephalitis 691 
endocrinological parameters 
- , serum 323 
— , circadian rhythms 323 
—, urine 323 
— , circadian rhythms 323 
ß-endorphin 
- , radioimmunoassay 724 
enzyme see also enzymes 
- , assay 706 
— , centrifugal analyser 706 
- , electrodes 861 
— , creatine 861 
— , creatinine 861 
— , in vivo monitoring 863 
- , pattern 603 
— , serum 603 
, liver metastases 603 
- , release 655 
— , cultured liver cells 655 
, chlorpromazine 655 
, digitonin 655 
enzyme immunoassay 
- , cannabinosid 724 
- , calculation 728 
chloramphenicol 879 
- , chorionic gonadotropin 
764 
- , Cortisol 659 
- , disopyramide 687 
- , elastase 232 
— , leukocytes 232 
- , ferritin 217, 599 
(Xi -fetoprotein 216, 699, 
702 
—, gentamycin 659 
- , IgE 814 
—, lipase 
— , pancreatic 683 
- , marker 435 
— , horseradish peroxidase 
435 
, chromogens 435 
- , methotrexate 660 
—, myelin basic protein 1067 
— , plasma 1067 
- , netilmicin 873 
—, oestrogens 809 
- , oestrone-3-glucuronide 
824 
- , phosphatase, acid 590 
- , prealbumin 837 
- , pregnancy specific ßi-gly-
coprotein 943 
- , progesterone 602 
- , C-reactive protein 686 
—, retinol binding protein 837 
- , testosterone 659 
—, thyroglobulin 826 
- , thyrotropin 240,774,781 
- , thyroxine 710,781 
—, thyroxine-binding globulin 
217 
—, trace proteins 590 
- , triiodothyronine, 447, 911 
enzymes see also enzyme 
--, alcohol metabolizing 179 
— , hair roots 179 
—, Dupuytens contracture 
931 
- , fibroblasts 931 
—, D-glucose metabolizing 
790 
— , specificity 790 
, anomeric 790 
—, and infarct size 878 
—, kidney 1131 
— , and tetrathionate 1131 
—, leukaemia 744 
— , lymphoblastic 744 
- , lysosomal 853 
X X X I 
enzymes see also enzyme 
—, lysosomal 
— , pleural effusions 853 
, SanfHippo syndrome 
220 
—, microsomal 1181 
, human tissues 1181 
, catalytic concentrations 
1181 
, lectin affinity 1181 
, multiple forms 1181 
- , palmar fascia 931 
- , pattern 829 
— , rat 829 
, nutrition 829 
—, peroxide metabolism 608 
—, phospholipid metabolism 
771 
, lung 771 
—, plasma 617 
, short term variations 
617 
—, release 843 
, erythrocytes 843 
, Duchenne muscular 
dystrophy 843 
—, serum 878 
— , asphyxia 878 
, infarct size 859 
, organ injury 782 
, ethanol 782 
— , ovary cancer 840 
—, turnover 736 
, liver 736 
, regulation 736 
- , urine 653, 852,1131 
, cisplatin 653 
— , and tetrathionate 1131 
enzymology 
—, clinical 529 
- , evolution 529 
EPH gestosis 173, 1211 
epilepsy 
—, carbamazepine 762 
epinephrine 
—, plasma 234 
error 
- , sources 115 
— , trace element analysis 
115 
- , sytematic 1063 
— , atomic absorption 
spectrometry 1063 
, calcium 1063 
erythrocyte 
—, adenine metabolism 670 
, Duchenne muscular 
dystrophy 670 
—, adenosine metabolism 670 
- , membrane 818 
— , acetylcholinesterase 818 
, Duchenne muscular 
dystrophy 818 
- - , ATPase 638 
, and radioprotectors 
638 
— , cholesterol 793 
—, metabolites 733 
— , shock 733 
- , sedimentation rate 687, 
700 
, Mortus Waldenstrom 
700 
- , volume 828 
— , alcohol abuse 828 
erythrocyte 
- , aminotransferases 719 
- , ATP 737 
— , sepsis 737 
—, bilirubin 371 
— , adsorption 371 
—, density 685 
— , after hypoxia 685 
- , enzyme release 843 
, Duchenne muscular 
dystrophy 843 




- , marker of maturity 854 
—, membrane vesicle release 
794 
, Duchenne muscular 
dystrophy 794 
Na/K ratio 856 
— , digitalis poisoning 856 
- , and oxygen saturation 521 
—, polyamines 877 
— , tumour markers 877 
- , potassium 737 
, sepsis 737 
—, ribonuclease 643 
—, sodium 737 
— , sepsis 737 
—, trinitrobenzene labelling 
672 
estimates of odds 1211 
ethane 1-hydroxy-l, 1-bisphos-
phonate 295 
- , crystal growth 295 
, inhibition 295 
ethanol 
- , organ injury 782 
, enzymes 782 
, serum 782 
ethosuximide 
—, serum 249 
— , enzyme immunoassay 
249 
, gas chromatography 249 
16a-ethyl-21 -hydroxy-19-nor-
4-pregnene-3,20-dione 801 
etioporphyrin I 44 
evaluation system 610 
Evans blue 
- , plasma 919 
, determination 919 
exercise 
- , glycogen metabolism 635 
- , lipoprotein cholesterol 
612 
—, metabolic response 873 
- - , and alcohol 873 
—, androgens 689 
— , plasma 689 
extraction 
—, anticonvulsants 594, 609 
—, steroids 71 
factor I I 89 
factor V I I I associated antigen 
611 
factor-X 
- , amidolytic assay 89, 242 
factor X I I 
—, assay 357 
factors 
- , non carboxylated 89 
FAD 
- , blood 236 
faeces 
bile acids 219 
— , extraction 219 
- , calcium 8.17 
—, chromium 817 
—, proteolytic activity 754 
- , trypsin inhibitor 754 
fatty acids 
- , adrenoleukodystrophy 
775 
interference 620 
— , creatinine assay 620 
ferritin 
- , serum 598, 599 
— , enzyme immunoassay 
225, 599 
— , immunoradiometry 947 
— , liver disease 690 
— , method comparison 947 





—, method comparison 692 
—, oligosaccharides 784 
— , liver diseases 784 
—, turbidimetry 839 
fibroblasts 
- , DMA 931 
—, enzyme activities 931 
—, skin 622 
— , 2-aminobutyrate 
oxidation 622 
fibronectin 
- , immunoturbidimetry 221, 
1213 
—, interaction with Clq 771 
—, laser nephelometry 221 
1213 
- , plasma 851 
— , immunoturbidimetry 
851 
flame photometry 
- , history 491 
flow diagram 
—, albumin 169 
— , bromcresol green method 
169 
—, cholesterol 307 
flow injection analysis 778 
flow through system 
—, Potentiometrie 49 
— , flow-optimized 49 
fluorescein dilaurate test 
745 
—, pancreas function 745 
fluorescence 
- , analysis 805 
- , yield 726 
— , protein assay 726 
fluoride 
—, analyzer 602 
— , glucose 602 
, determination 602 
—, sensitive electrode 838 
— , peroxidase assay 838 
- , urine 1039 
— , reference values 1039 
fluorimetry 689 
—, neuraminidase 857 
- , proteinase 238 
—, trypsinogen 816 
fluorine 
—, exposure 785 
— , screening 785 
fluorocarbons 267 
fluoroimmunoassay 
—, aminoglycosides 244 
- , IgG 241 
fluorosis 608 
5-fluorouracil 
- , HPLC 704 
FMN 
- , blood 236 
foetal distress 654 
a-foetoprotein 
—, amniotic fluid 787 
—, cord blood 787 
—, enzyme immunoassay 216, 
699, 702 
- , foetal distress 654 
—, serum 845 
— , immunoassay 845 
—, tumour marker 216 
—, urine 787 
— , newborn 787 
folate 
- , assay 738 
- , binding protein 702 
—, haemoglobin binding 757 
- , radioassay 702 
—, renal failure induction 
794 
- , serum 635 
— , radioassay 635 
follitropin 
- , serum 649 
— , radioimmunoassay 649 
—, urine 649 
— , radioimmunoassay 649 
food 
—, calcium 817 
—, chromium 817 
fractionation 
—, steroids 71 
fragmentography 
- , androstanediols 853 
— , plasma 853 
frequency 
- , inherited diseases 706 
fucosyltransferase 
- , serum 744 
— , tumour marker 744 
furosin 
- , HPLC 81 
galactosamine 
—, hepatitis 363 
— , glycosaminoglycans 363 
, synthesis 363 
galactose 
—, absorption 621 
— , after oral administration 
621 
- , metabolism 780 
— , and small bowel 
structure 780 
- , tolerance 776 
— , cataract 776 
galactose oxidase 
- , glycoprotein assay 814 
/3-galactosidase 
- , kidney 1132 
—, urine 1132 
gangliosides 
—, serum 847 
X X X I I 
gangliosides 
serum 
— , extraction 847 
gas chromatography 
- , amino acids 767 
- , antiepileptics 305, 839 
- , carbamazepine 249 
- , clinical chemistry 241 
- , diphenhydramine 740 
—, ethosuximide 249 
—, 2-oxo-5-guanidinovaleric 
acid 61 
- , phenobarbital 249, 305 
—, phenytoin 249, 305 
—, phytanic acid 224 
—, polyethylene glycol 400 
265 
— , urine 265 
- , primidone 249, 305 
- , steroids 688, 786 
— , urine 688 
- , 4-sulphoxy-3-methoxy-
phenylethyleneglycol 616 
—, toxicology 627 
- , valproic acid 711, 763 
- , zipeprol 25 
gas-liquid chromatography 
mexiletine 1189 
— , serum 1189 
gasometric analysis 
- , history 491 
gastrin 
—, radioimmunoassay 724 
genetic disorders 
—, prenatal diagnosis 583 
genital tract 
- , female 647 
— , vitamin A acid binding 
protein 647 
gentamicin 
- , enzyme immunoassay 659 
- , serum 762 
gestosis 
—, uric acid 173 
— , decision criteria 173 
globulin 
- , cold insoluble 1213 
globulins see also Ig, im-
munoglobulins 
- , calcium binding 598 
glomerular filtration rate 
—, cyanocobalamin 629 
glucaric acid 
- , urine 720, 875 
— , drug metabolism 875 
— , liver function 875 
glucocorticoids 
- , HPLC 659 
—, pharmacokinetics 659 
gluconeogenesis 
—, 3-hydroxy-3-methyl~ 
glutarylCoA lyase 240 
- , deficiency 831 
glycosaminoglycans 
- , liver 867 
glucose 
- , assay 742, 816 
, method comparison 742 
—, chemiluminescence assay 
639 
- , determination 227, 602 
, fluoride analyzer 602 
, multi-layer film technol-
ogy 227 
—, interference 772 
glucose 
- , interference 
— , amylase assay 772 
- , plasma 239, 678 
— , kinetic assay 239 
- , serum 239, 675, 859, 977 
— , determination 977 
, methodology 977 
— , kinetic assay 239 
- , tolerance 777 
- , tolerance test 633 
- , tumour 777 
glucose-6-phosphate dehydro-
genase 636 
—, erythrocytes 636 
D-glucose 
—, enzymes 790 
— , specificity 790 
, anomeric 790 
a-glucosidase 
- , amniotic fluid 803 
glucosyl-galactosyl-hydroxy-
lysine 
- , glucohydrolase 851 
glutamate dehydrogenase 
- , alcohol abuse 828 
- , kidney 1132 
- , urine 1132 
glutamic acid 
—, plasma 1194 
glutamine 
—, plasma 1194 
y-glutamyl transferase 
- , alcohol abuse 828 
- , alcoholism 689 
- , carcinogenesis 682 
control sera 719 
- , kidney 1132 
- , liver 682 
microsomal 1181 
— , human tissues 1181 
, catalytic concentrations 
1181 
, lectin affinity 1181 
, multiple forms 1181 
- , and phenobarbitone 632 
- , plasma 682 
- , substrate solubility 727 
- , serum 803, 880 
— , multiple forms 880 
— , ß-thalassaemia major 
803 
- , urine 1132 
y-gl utamyltranspeptidase 
- , urine 729 
L-Y-glutamyl-4-nitroanilide 
- , solubility 727 
glutathione peroxidase 
- , blood 617 
— , horse 617 
glycerate 2,3-bisphosphate 
- , diabetes 602, 750 
— , and glycosylated haemo-
globin 602 
- , erythrocytes 521, 733 
— , and oxygen saturation 
52.1 
glycerol phosphatides 
- , serum 7 
— , determination 7 
, enzymatic 7 
glycine 
- , plasma 1194 
glycogen 
- , Phosphorylase 635, 809 
glycogen 
- , Phosphorylase 
, exercise 635 
, serum 809 
, myocardial infarction 
809 
—, synthetase 635 
— , exercise 635 
glycolysis 
- , muscle 723 
glycoprotein 
- , assay 814 
— , galactose oxidase 814 
glycoproteins 
—, N-acetylneuraminic acid 
31 
, determination 31 
, micromethod 31 
—, cancer 596 
9.5 S ai-glycoprotein 1201 
glycosaminoglycans 
—, estimation 221 
— , laser nephelometry 221 
- , fibroblasts 809 
, Dupuytren's contracture 
809 
—, serum 775 
— , atherosclerosis 775 
- , synthesis 220, 363, 465 
— , liver 220, 363 
, liver, rat 465 
, galactosamine hepati-
tis 363 
—, urine 220 
, Sanfilippo syndrome 220 
glycosyl-albumin 81 
glycosylation 
- , haemoglobin 765, 1097 
— , method comparison 
1097 
- , non enzymatic 81 
gonadotropins 
- , diabetes 593 
gonads 
—, disorders 738 
— , chorionic gonadotropin 
738 
— , luliberin 738 
gout 
—, oxalic acid 630 
—, oxypurines 598 
- - , urine 598, 630 
Gorup-Besanez, von R. G. 
guanidinoacetic acid 
- , urine 65, 721 
4-guanidinobutyric acid 
—, urine 65 
guanidino compounds 673 
guanidinosuccinic acid 
—, urine 65 
haem . . . see also hem . . . 
haematological parameters 
—, circadian rhythms 323 
haematology 
—, horse 629 
—, neuroleptics 751 
- , quality control 220, 782 
haemiglobin 
—, determination 457 
— , multi-wavelength spec-
trometry 457 
haemiglobin cyanide 
—, molar lineic absorbance 
1209 
haemiglobin cyanide 
- , stability 1209 
haemiglobin reductase 
- , serum 766 
— , liver diseases 766 
haemodialysis 
- , acetate incorporation 651 
— , into cholesterol 651 
- , aluminium 826 
— , uptake 826 
- , aminotransferases 719 
- , apolipoproteins 660 
- , pyridoxal-5'-phosphate 
795 
— , plasma 795 
haemoglobin 
- , A, 223 
— , methodology 223 
- , circadian rhythms 323 
- , cyanide 521 
- , derivatives 521 
— , absorption spectra 521 
- , determination 457, 1209 
— , multi-wavelength 457 
- , free 971 
— , serum 971 
—, folic acid binding 757 
- , glycosylated 229, 237, 
602, 627, 639, 662, 695, 
704, 761, 776, 777, 783, 
790, 867 
— , assay 627 
— , diabetes 602, 761, 776, 
790 
, and glycerate 2,3-bis-
phosphate 602 
, HPLC 790 
— , method comparison 783 
— , reference values 229 
- , glycosylation 765, 1097 
— , method comparison 
1097 
- , interference 243 
— , bilirubin assay 243 
—, oxygen saturation 521 
— , and glycerate 2,3-bis-
phosphate 521 
—, reference method 517 
- , spectrophotometry 521 
haemoglobinometry 517 
haemopexin 




—, prostacyclin 666 
hair 
- , children 654 
— , trace elements 654 
- , follicle 865 
— , cell culture 865 
- , roots 179 
— , enzymes 179 
, alcohol metabolizing 
179 
haloperidol 
—, plasma 679 
haptoglobins 
- , distribution 698 
- , immunoturbidimetry 788 
- , and myocardial infarction 
634 
HDL 
—, apolipoproteins 1 
—, apolipoprotein A I 273 
X X X I I I 
HDL 
—, apolipoprotein A I 
— , serum 273 
, determination 273 
cholesterol 1, 240, 273, 
614, 627, 636, 662, 685, 
725, 743, 746, 751, 850 
— , circadian variations 751 
— , control serum 636 
— , coronary heart disease 
743, 725 
— , hyperlipoproteinaemia 
614 
— , myocardial infarction 
662 
— , reference value 240 
— , serum 273, 627, 746 
, coronary artery disease 
627 
, determination 273 
, low caloric diet 746 
—, isolation 1 
—, isotachophoresis 620 
- , lipaemia 797 
— , alimentary 797 
—, serum 720 
- , subclasses 644 
subfractions 712 
— , characteristics 712 
- , thyroid dysfunction 605 
heart 
- , cells 619 
— , rat 619 
, function 619 
, and bile salts 619 
- , cystyl aminopeptidase 145 
heat inactivation test 
- , thermostable creatine 
kinases 1021 






- , liver 363 
- , synthesis 465 
— , liver, rat 465 
heparinate 
- , effects 825 
— , methodological 825 
hepatitis 
- , cystyl aminopeptidase 145 
- , lipids 814 
- , lipoproteins 814 
hepatitis B 
—, immunoglobulins 13 
— , determination 13 
— , standardisation 13 
—, lactate dehydrogenase 755 
— , serum 755 
- , serum 283 
— , cytotoxicity 283 
hepatobiliary diseases 605 
hepatocytes 
- , rat 283 
— , culture 283 
hexosaminidase 
—, deficiency 584 
- , metabolic disorders 735 
high altitude 
- , electrolytes 606 
—, lactate dehydrogenase 606 
— , myocardium 606 
— , serum 606 
high performance gel filtration 
- , apolipoproteins 872 
high performance liquid 
chromatography see also 
HPLC 
- , catecholamines 217, 841 
—, creatinine 886 
- , furosin 81 
— , from glycosylated 
proteins 81 
- , 4-hydroxy-3-methoxy-
mandelic acid 214 
- , 4-hydroxy-3-methoxy-
phenylacetic acid 214 
- , hydroxy-vitamin D 1043 
- , N'-methyladenosine 55 
- , N7-methylguanosine 55 
- , pyridoxal-5'-phosphate 
237 
- , retinol 235 
- , serum 885 
- , thiamine 237 
—, Y - t o c o pheT° l 235 
- , vitamin B 2 236 
— , derivatives 236 
histamin 
- , gastric juice 683 
hist i dine 
- , plasma 1194 
history 
- , Boerhaave, Hermann 230 
- , chemistry 497 
— , Erlangen 497 
- , clinical chemical instru-
mentation 491 
—, Clinical Chemistry 309, 
311 
- , enzymology 529 
— , clinical 529 
- , medicine 497 
— , Erlangen 497 
- , urine examination 739 
Hitachi ABCA 706 D 751 
homochlorcyclizine 
- , liver 745 
effects 745 
homovanillic acid 
- , urine 323 
— , circadian rhythms 323 
hormone 
- , assay 834 
— , quality control 834 
hormones 
- , enzyme turnover 736 
— , liver 736 
- , plasma 846 
— , hyperinsulinism 846 
horse 
- , blood 617 
— , glutathione peroxidase 
617 
— , selenium 617 
- , haematology 629 
- , lactate 629 
HPLC see also high perform-
ance 
- , acyl-CoA 664 
- , amiodaron 599 
analgesics 610 
- , andrology 785 
- , anticonvulsants 594 
- , apolipoproteins 812 
- , bilirubin species 748 
—, clinical chemistry 753 
- , CoASH 664 
HPLC see also high 
performance 
- , corticoids 823 
- , Cortisol 659, 746, 804 
- , creatinine 375 
—, cyanocobalamin 629 
— , glomerular filtration rate 
629 
—, 11-deoxycortisol 804 
- , disopyramide 687 
- , drug metabolism 783 
- , drug monitoring 625 
- , 5-fluorouracil 704 
- , gentamicin 762 
- , glucocorticoids 659 
—, haemoglobin 790 
— , glycosylated 790 
- , 6ß-hydroxycortisol 525 
— , urine 525 
—, insulins 641 
- , neurotransmitters 813 
- , nucleosides, modified 639 
—, organic acids 625 
- , oxosteroids 727 
— , fluorescence detection 
727 
- , peptide separation 832 
- , porphyrins 771 
- , purine nucleotides 595 
—, pyrimidine nucleotides 
595 
- , retinol 657 
- , steroids 610 
—, tetramycin 762 
- , uric acid 708 
valproic acid 658 
- , vitamin E 614 
— , serum 614 
human placental lactogen 
- , serum 803, 866 
— , pregnancy 803 
— , radioimmuno assay 866 
hydralazine 
- , manganese complexes 
716 




- , Potentiometrie assay 838 
—, substrates 861 
hydroxyacids 
- , serum 640 
hydroxyapatite 
- , from amorphous calcium 
phosphate 782 
18-hydroxycorticosterone 387 
- , plasma 387 
— , radioimmunoassay 387 
18-hydroxydeoxycorticosterone 
- , plasma 387 
— , radioimmunoassay 387 
6/8-hydroxycortisol 
- , urine 525 
— , HPLC 525 
— , radioimmunoassay 525 
hydroxy ethyl starch 
- , pharmakokinetics 696 
5-hydroxy-3-indole acetic acid 
- , urine 837 
3- hydroxyisoheptanoic acid 
750 
4- hydroxyisovaleric acid 750 
hydroxylysine 
- , collagen 761 
4-hydroxy-3-methoxy-
mandelic acid 214 
—, urine 
4-hydroxy-3-methoxy-phenyl-




- , urine 647 
— , diabetes 647 
3 - hyd roxy - 3 - me t h \ lgl u I a ry I 
CoA lyase 
—, deficiency 831 
17-hydroxyprogesterone 
—, amniotic fluid 665 
hydroxyproline 
serum 654, 679, 859 
— , rheumatoid arthritis 859 
- , synovial fluid 859 
— , rheumatoid arthritis 859 
—, urine 209 
3-hydroxyproline 
- , urine 617 
25-hydroxy vitamin D 662 




— , urine 61 
hypercalcaemia 
- , differentiation 703 
- , hyperparathyroidism 692 
hyperimmunoglobulins 13 
hyperinsulinism 
- , hormones 846 
— , plasma 846 
hyperlipaemia 
—, clearing 799 
— , serum 799 
hyperlipoproteinaemia 884 
- , apolipoproteins 614 
- , HDL-choIesteroI 614 
- , screening 856 
hyperparathyroidism 
—, hypercalcaemia 692 
hypertension 
- , pregnancy 688 
- - , steroids 688 
, urine 688 
hypothyreosis 
—, screening 774, 819 
hypoxia 
- , density 685 
, erythrocytes 685 
—, indicators 687 
1CP emission spectroscopy 
- , boron 830 
identification 
- , positive 682 
— , patient 682 
IgE 
- , assay 768 
- , enzyme immunoassay 814 
—, immunoassay 598 
IgG 
—, cerebrospinal fluid 241 
— , fluoroimmunoassay 241 
— , immunoturbidimetry 
823 
— , multiple sclerosis 630 
lgM 
- , morbus Waldenstrom 700 





— . oestrogen effects 694 
immune response 
—. duodenum 843 
—. humoral 665 
— . CNS 665 
stomach 843 
immunocomplexes 
- , assay 760, 774 
immunoelectrophoresis 
- , phosphatase, alkaline 594 
— , bone 594 
—, proteins 866 
immunofixation electrophore-
sis 669 
- . immunoproteins 669 
immunoglobulins 
- , abnormal molecular weight 
802 
- , assay 826 
- , cerebrospinal fluid 743 
— , turbidimetry 743 
- , hepatitis B 13 
— , determination 13 
, standardisation 13 
macroamylasaemia 618 
—, quantitation 628 
—, serum 67 
— , turbidimetry 67 
immunoglobulin G 
—, binding 925 
— , of creatine kinase BB 
925 
immunoinhibition 
—, creatine kinase 816 
- . creatine kinase MB 231 
- , creatine kinase M subunit 
543 
immunonephelometry 
—, apolipoproteins 864 
- , carbamazepine 784 
- , methodology 873 
immunoprecipitation 
—, lactate dehydrogenase 628 
immunoproteins 
- , immunofixation electro-
phoresis 669 
immunoradiometry 
- , ferritin 947 
immunoturbidimetry 
- , albumin 808, 823 
— , cerebrospinal fluid 823 
—, apolipoproteins 232 
- , fibrinogen 692 
fibronectin 221,851, 1213 
— , plasma 851 
- , haptoglobin 788 
- , IgG 823 
— , cerebrosphinal fluid 823 
—, proteins 645 
— , serum 645 
indocyanine green 797 
indometacin 387 
- , prostaglandins 753 
— , urine 753 
infarct see also coronary 
heart disease, myocardial 
infarction 
- , size 859, 878 
, enzymes 878 
— , ultrastructure 878 
infertility 
- . phosphatase, acid 626 
. seminal fluid 626 
infertility 
- , zinc 626 
— , seminal fluid 626 
inflammation 
- , carrageenin 784 
— , lipid peroxide 784 
— , protease 784 
—, complement 758 
- , and copper 684 
information content 173 
information theory 585 
inherited diseases 
- , frequency 706 
—, screening 706 
inherited disorders 
—, hexosaminidase 735 
inhibitors 
- , amylase 853 
- . clavulanic acid 953 
— , ß-lactamase 953 
—, collagenase 622 
- , converting enzyme 387 
— , Captopril 387 
—, penicillins 953 
— , ß-lactamase 953 
—, protease 643 
instrumentation 754 
- , history 491 
insulin 
- , bovine 641 
— . HPLC 641 
- . C-pcptide 234 
- , clearance 710 
- , diabetes 729 
- , porcine 641 
— , HPLC 641 
- , postprandial 773 
- , radioimmuno assay 441 
— , standard curve 441 
, suitable functions for 
441 
- , receptor 714 
intensive care 765 
interactions 
- , drugs 646 
interfacial tension 267 
interference 
—, atomic absorption spectro-
metry 1063 
— , calcium 1063 
- , bilirubin 611 
—, Jaffe reaction 611 
- , creatinine assay 620 
- - , fatty acids 620 
- , danazol 835 
— , testosterone assay 835 
- , drugs 249 
— , antiepileptics assay 249 
—, glucose 772 
— , amylase assay 772 
- , lipase 722 
— , serum 722 
interlaboratory trial 
- , calcium 395, 413 
- , guide lines 413 
interpretation 
- , laboratory results 870 
intestine 
- , cystyl aminopeptidase 
145 
- , permeability 265 
— , measurement 265 
intraindividual ranges 
- , clinical chemical para-
meters 674 
intrinsic factor 
—, cobalamin assay 811 
invertase 
—, duodenal mucosa 39 
— , determination 39 
, spectrophotometric 39 
Iodogen 1051 
3'-iodo-L-thyronine 195 
iodothyronines 191, 195 
- , substitution 191, 195 
— , with bromine 191, 195 
— , with I 2 5 I 191, 195 
ion exchange chromatography 
—, guanidines 61 
—, macro creatine kinase 849 
ion selective electrodes 764 
—, potassium 640 
—, sodium 640 
ion sensitive electrodes 
- , lead 629 
—, potassium 668 
—, sodium 668 
iron 
—, absorption 658 
— , iraemia 658 
—, assay 779 
—, binding capacity 686 
—, complexes 43 
- , proton-induced X-ray 
emission 887 
—, saturation 731 
— , transferrin 731 
- , serum 219, 323, 967 
— , circadian rhythms 323 
— , coulometry 967 
, potentiostatic 967 
, reference values 219 
isoamylase 
- , clinical value 711 




—, alcohol dehydrogenase 179 
—, aldehyde dehydrogenase 
179 
- , amylase 218, 231, 711, 
768, 787, 815, 840, 847, 
854 
— , determination 840 
— , ovary cancer 815 
— , pancreatitis 815, 847 
— , serum 768 
- , creatine kinase 239, 674, 
732, 756, 758, 806, 816, 
1021 
— , assay 816 
, cerebrospinal fluid 756 
- - , heat stability 1021 
— , MB 806 
, method comparison 
806 
—, Michaelis constant 239 
— , muscle 732 
, plasma 758 
, cardiovascular surgery 
758 
—, enzymes 1181 
— , microsomal 1181 
—, glycogen Phosphorylase 
809 
- , lactate dehydrogenase 
668, 755, 865 
- - , hepatitis B 755 




- , phosphatase, acid 835 
- , phosphatase, alkaline 748, 
800 
— , cholestasis 748 
- , serum 782 
— , organ injury 782 
, ethanol 782 
isoleucine 
—, nitrogen metabolism 828 






- , HDL 620 
isovaleric acidaemia 750 
N-isovalerylglutamic acid 750 
ixoten 669 
jejunoileal bypass 601, 672 
—, bile acids 601 
jejunum 
- , mucosa 1181 
— , enzymes 1181 
joint 
—, diseases 736 
— , synovial fluid 736 
kallikrein 
—, determination 165 
— , urine 165 
, substrate 165 
- , plasma 1033 
— , rat 1033 
urine 1033 





—, carcinoma 700 
— , aminopeptidase M 700 
- , cystyl aminopeptidase 145 
- , disease 758 
— , complement 758 
— , enzymuria 729 
— , proteinuria 729 
— , urokinase 794 
, urine 794 
- , dysfunction 709 
— , liver damage 709 
- , enzymes 1131, 1181 
— , and tetrathionate 1131 
- , failure 704 
— , alanine aminopeptidase 
704 
- , function 721 
— , guanidinoacetic acid 721 
- , lysozymuria 703 
- , stones 594 
— , identification 594 
—, transplantation 719, 720 
- , tubular disorders 236 
— , ß2-microglobulin 236 
, urine 236 
Kodak EKTACHEM 227, 
613, 752, 804 
KONE CD 
- , evaluation 1027 




— , clinical chemistry 580 
—, performance 628 
- , results 
— , interpretation 870 
—, structure 834 
/3-lactamase 279, 953 
—, inhibition 953 
- , kinetics 953 
- , substrate binding sites 953 
lactate 
—, determination 877 
— , with APAD 877 
- , horse 629 
lactate dehydrogenase 
detection 884 
—, gastric juice 719 
— , cancer 719 
- , immunoprecipitation 628 
—, isoenzyme-1 628 
— , myocardial infarction 
628 
- , isoenzymes 668, 755, 865, 
883 
- - , hepatitis B 755 
— , serum 668 
- . kidney 1132 
myocardium 606 
— , high altitude 606 
- , serum 606, 767 
- - , cold lability 767 
— , high altitude 606 
- , sperm 883 
- , subunit M. deficiency 723 
- , urine 1132 
- , zymogram 867 
laser nephelometry 
- , antithrombin-III 796 
- , apolipoproteins 765 
- , methodology 838 
- , rheumatoid factor 1125 
latex immunoassay 




- , blood 835 
—, bone 715 
—, excretion 21 
— , and ambilhar 21 
—, ion sensitive electrode 629 
—, mobilisation 21 
— , and ambilhar 21 
- , urine 835 
lecithin 
- , administration 779 
- - , lipids 779 
- , amniotic fluid 225, 728 
— , enzymatic assay 728 
lecithin: cholesterol acyltrans-
ferase 
- , assay 653 
- , plasma 827 
— , ß-blocker 827 
lecithin/sphingomyelin ratio 
amniotic fluid 219, 807 
lectins 1201 
lectin affinity 
—, enzymes 1181 
— , microsomal 1181 
, human tissues 1181 
lectin-like properties 
—, acute phase proteins 1201 
legionellosis 690 
leucine 
- , nitrogen metabolism 828 
- , plasma 1194 
leucine aminopeptidase 
—, kidney 1132 
—, urine 1132 
leukaemia 
- , cells 744 
— , ATP 744 
, cytostatics 744 
- , lymphoblastic 744 
— , enzymes 744 
leukocytes 
- , analyser 731 
—, chemiluminescence 843, 
864 
- , elastase 232 
— , enzyme immunoassay 
232 
- , urine 231 
— , test strip 231 
leupeptin 
—, and oestrogen receptors 
688 
lidocaine 
- , plasma 651 
— , peridural anaesthesia 
651 
lignans 
—, urine 597 
light scattering 233 
- , proteins 
likelihood quotient line 1211 
lipaemia 
- . alimentary 797 
— , HDL 797 
lipase 
—, pancreatic 683 
— , enzyme immunoassay 
683 
- , serum 225, 722, 735 
— , age dependence 735 
— , interferences 722 
— , method comparison 225 
lipid peroxides 
—, atherosclerosis 789 
—, carrageenin inflammation 
784 
lipids 
- , hepatitis 814 
—, myocardial infarction 605, 
833 
—, peroxidation 608 
- , plasma 791, 827 
— , ß-blocker 827 
— , distribution 791 
— , variability 827 
- , schistosomiasis 729 
- , serum 636, 800, 806, 852 
— , atherosclerosis 806 
— , burn disease 800 
— , polychlorinated biphenyl 
poisoning 636 
lipopolysaccharides 
- , and prostaglandin synthesis 
675 
lipolysis 
- , adipocytes 812 
lipoproteins 1 
- , cholesterol 217, 612, 658, 
742, 857, 881 
— , capillary blood serum 
742 
— , transfer 857 
- , and diet 779 
lipoproteins 
—, electron spin resonance 
707 
- , electrophoresis 620, 701 
— , quantitative 620 
— , reference values 701 
- , exercise 612 
- , fractionation 874 
- , hepatitis 814 
- , metabolism 715 
— , sex differences 715 
—, phospholipids 792 
—, plasma 791 
— , distribution 791 
- , precipitation 273 
- , quantitation 869 
- , serum 696, 642, 738, 806 
— , atherosclerosis 806 
— , children 606 
, pneumonia 606 
— , coronary artery disease 
642 
— , method comparison 738 
lipoprotein X 
- , alkaline phosphatase 
complex 242 
—, cholestasis 759 
- , determination 155 
— , enzymatic 155 
- , serum 798 
lithium 
—, serum 672 
— , renal failure 672 
liver 
- , blood flow 797 
- , cancer 707, 791 
— , 5'-nucleotide phospho-
diesterase 707 
— , screening 791 
—, carbon tetrachloride posin-
ning 597 
- , cells 757 
— , zinc 757 
, porphyria 757 
— , zinc binding proteins 
757 
, porphyria 757 
- , cystyl aminopeptidase 145 
—, damage 709 
— , kidney dysfunction 709 
- , disease 145, 601, 690 
— , cystyl aminopeptidase 
145 
- - , ferritin 690 
, serum 690 
— , screening 601 
diseases 593, 699, 760, 
766, 784 
— , aspartate aminotrans-
ferase 699 
, mitochondrial 699 
— , bile acids 760 
, serum 760 
— , haemiglobin reductase 
766 
, serum 766 
— , oligosaccharides 784 
, fibrinogen 784 
— , selenium 593 
, serum 593 
- , DNA-synthesis 680 
- , enzymes 1181 
- , enzyme turnover 736 
— , regulation 736 
- , function 803, 875 
liver 
—, function 
— , glucaric acid 875 
, urine 875 
— , pregnancy 803 
- , y-glutamyltransferase 682 
- , glycosominoglycans 363, 
867 
— , synthesis 363 
, galactosamine hepatitis 
363 
- , Guinea pig 632 
— , Y-glutamyltransferase 
632 
, and phenobarbitone 
632 
- , homochlorcyclizine 745 
— , effects 745 
- , injury 669, 680, 684 
— , proteins 669 
, plasma 669 
— , proteoglycan synthesis 
684 " 
- , insufficiency 159 
— , polyamines 159 
, plasma 159 
- , lead 21 
- , metastases 603, 1181 
— , enzymes 1181 
— , enzyme patterns 603 
, serum 603 
- , necrosis 705 
— , y-glutamyltransferase 
705 
, serum 705 
—, phosphatase, alkaline 833 
- , rat 465, 596, 829 
— , enzyme pattern 829 
— , glycosaminoglycan 
synthesis 465 
— , phosphatase alkaline 
596 
—, resection 220 
— , glycosaminoglycan 
synthesis 220 
- , toxicity 848 
— , antirheumatics 848 
longitudinal variations 674 
Lp(a) 
—, atherosclerosis 763 
- , myocardial infarction 763 
luciferase 581, 749 
lucigenin 583 
luliberin 
- , gonadal disorders 738 
luminol 583 
luminescence 
- , analysis 581, 582, 
- , phagocytosis 581, 582 
luminescene immunoassay 
—, Cortisol 771 
luminometry 
—, nucleotides 666 
lung 
—, phospholipid metabolism 
771 
— , enzymes 771 
tumour cells 657 
— , cold agglutinin receptors 
657 
lupus erythematosus 
- , DNA 691 
— , plasma 691 
- , DNA antibodies 691 
— , plasma 691 
X X X V I 
lutropin 
—, serum 649 
— , radioimmunoassay 649 
- , urine 649 
— , radioimmunoassay 649 
lymphocyte 
- , capping 681 
—, neuraminidase 857 
—, thymidine 855 
— , transport 855 
lymphokine 855 
lysine 
- , plasma 1194 
lysozyme 
—, cerebrospinal fluid 726 
—, serum 726 
- , urine 703 
macro amylase 239, 241 
—, serum 241 
— , immunoglobulins 618 
macro creatine kinase 239, 
619, 849,1021 
—, characteristics 619 
- , different forms 849 
—, heat inactivation test 1021 
macro creatine kinase BB 925 
cx2-macroglobulin 
—, cerebrospinal fluid 287, 
732 
— , assay 287 
, amidolytic 287 
—, complex with trypsin 287 
- , plasma 877 
— , chromogenic substrate 
877 
, reference values 877 
serum 287. 877 
— , assay 2<S 7 
, amidolytic 287 
— , chromogenic substrate 
877 
, reference values 877 
- , trypsin complex 643 
— , and protease inhibitors 
643 
magnesium 
- , blood 696 
— , burn disease 696 
—, brain 696 
— , burn disease 696 
- , heart 696 
— , burn disease 696 
- , liver 696 
— , burn disease 696 
- , serum 323, 595 
— , circadian rhythms 323 
— , coronary heart disease 
595 
malignant diseases see also 
cancer, carcinoma, neo-
plasms, tumour 
- , sialic acid 623 
, serum 623 
maltoheptaose 213 
maltopentaose 
- , a-amylase assay 708 
manganese 
—, complexes 716 
, hydralazine 716 
mannitol 
- , serum 139 
, determination 139 
, enzymatic 139 
mass spectrometry 
- , amino acids 767 
—, analgesics 610 
- , doxylamine 485 
- , 2-oxo-5-guanidinovaleric 
acid 61 
- , steroids 610 
—, toxicology 627 
- , zipeprol 25 
matrix 
- , effects 835 
— , lead assay 835 
— , pregnancy specific ß\ -gly-
coprotein 1197 
, radio immunoassay 
1197 
, serum 1197 
maturity 
- , erythrocytes 854 
MD-Kova-System 587, 588 
meconium 
- , proteolytic activity 754 
- , trypsin inhibitor 754 
medical decision 
—, and clinical chemistry 677 
—, making 1211 
melanoma 
- , la like antigens 878 
— , radioimmunoassay 878 
- , polyamines 652 
- - , blood 652 
— , plasma 652 
membrane 
- , vesicles 794 
— , erythrocytes 794 
, release 794 
, Duchenne muscular 
dystrophy 794 
meningitis 
—, C-reactive protein 819 
—, sialic acid 623 
— , cerebrospinal fluid 623 
menstrual cycle 




- , pharmacokinetics 595 
mercury 
—, urine 471 





organic acids 625 
— , HPLC 625 
metal binding 
- , metronidazole 661 
methaemoglobin 
- , pancreatitis 847 
methionine 
- , plasma 1194 
method comparison 
- , albumin 797 
- , a-amylase 1057 
- , antiepileptics 813 
- , carbamazepine 249 
- , CEA 961 
- , cephalexin 35 
- , cobalamin 738 
- , creatinine 601 
- , creatine kinase-MB 806 
- , ethosuximide 249 
- , evaluation 681 
method comparison 
- , ferritin 947 
- , folate 738 
—, glucose 742 
- , glycosylation 1097 
— , haemoglobin 1097 
- , haemoglobin 783 
— , glycosylated 783 
- , 6ß-hydroxycortisol 525 
- , lipase 225 
- , lipoproteins 738 
— , serum 738 
- , lipoprotein X 155 
- , methodology 868 
—, multivariate approach 121 
- , phenobarbital 249 
- , phenytoin 249 
—, pregnancy specific ßi-gly-
coprotein 943 
—, primidone 249 
- , protein 203 
— , urine 203 
- , random bias 855 
- , thyroxine 453 
- , thyroxine, free 846 
- , triiodothyronine 447, 911 
- , valproic acid 743 
method, definitive 
calcium 395, 413 
3-methoxy-4-hydroxy-




—, enzyme immunoassay 660 
- , pharmacokinetics 882 
- , toxicity 882 
- , and proteins 667 
— , serum 667 
N'-methyladenosine 




- , deficiency 692 
N7-methylguanosine 
- , urine 55 
NT-methylhistamine 226 
- , serum 
- , urine 
3-N-methylhistidine 819 
methylphenobarbitone 
- , bioavailability 741 
- , metabolism 741 
methylprednisolone 




—, metal binding 661 
metyrapone 75 
mexiletine 
- , serum 1189 
— , gas-liquid chromato-
graphy 1189 
Michaelis constant 239 





—, serum 709 
ß2-microglobulin 
- , breast cancer 339 
- , latex immunoassay 613 
(^-microglobulin 
- , serum 709 
- , urine 695, 236 





- , enzymes 1181 
mitochondria 
- , ascorbate transport 708 
mitogen 
- , stimulation 604 
molar lineic absorbance 
- , haemiglobin 1209 
- , haemoglobin 521 
molybdenum 
—, complexes 716 
— , hydralazine 716 
molybdate 
- , and oestrogen receptors 
688 
monitoring 
—, continuous 863 
— , enzyme electrodes 863 
- , drug 818 
- , pregnancy 803, 804 
monoamine oxidase 
- , serum 792 
— , connective tissue diseases 
792 
mouse 
clinical chemistry 644 
— , and diet 644 
morphine 
graft 724 
— , transfer with 724 
morbus Waldenstrom 
- , erythrocyte sedimentation 
rate 70 
- , lgM 
moxestrol 650 
M-protein 
- , myeloma 730 
multiple forms 
—, enzymes 1181 
— , microsomal 1181 
- , y-glutamyl transferase 880 
— , serum 880 
multi-layer film technology see 
also Kodak EKTACHEM 
- , calcium 227 
—, glucose 227 
- , urea 227 
multiple sclerosis 
- , albumin 630 
— , cerebrospinal fluid 630 
- , IgG 630 
— , cerebrospinal fluid 630 
—, trace elements 813 
— , blood 813 
muscle 
- , creatine kinase MB 732 
- , lactate dehydrogenase 723 
— , subunit M deficiency 
723 
—, metabolism 705 
muscular dystrophy 
-, Duchenne 670, 681, 794, 
818, 828 
— , acetylcholinesterase 818 
, erythrocyte mem-
brane 818 
— , erythrocytes 843 




— , screening 828 
muscular syndrome 539 
myelin basic protein 
- , plasma 1067 
— , enzyme immunoassay 
1067 
myeloma 666 
- , M-protein 730 
myocardial infarction see also 
coronary heart disease, 
infarct 
- , apolipoproteins 605 
- , collagen metabolism 739 
- , creatine kinase 674 
- , diabetics 662 
— , haemoglobin 662 
, glycosylated 662 
— , HDL-cholesterol 662 
—, glycogen Phosphorylase 
809 
- - , serum 809 
—, and haptoglobin 634 
- , HDL cholesterol 1 
- , lactate dehydrogenase 
isoenzyme-1 628 
- , lipids 605, 833 
- , Lp (a) 763 
- , myoglobin 634, 807 
- - , release 807 
— , serum 634 
myocardium 
—, electrolytes 606 
- - , high altitude 606 
- , lactate dehydrogenase 606 
- - , high altitude 606 
myoglobin 
- , progressive muscular 
dystrophy 861 
- , release 807 
— , myocardial infarction 
807 
- , serum 634, 213 
— , after exercise 213 
— , myocardial infarction 
634 
myometrium 
—, oestrogen receptor 688 
myopathy 
- , myoglobin 636 
— , serum 636 
nembutal 
—, vanilmandelic acid 987 
- , anaesthesia 987 
— , noradrenaline 987 
, metabolism 987 
, rat brain 987 
neonates 
- , prolactin 853 
— , serum 853 
neoplasms see also cancer, 
carcinoma, malignant 
diseases, tumour 
- , haematological 694 
— , neopterine 694 
, urine 694 
neopterine 
- , urine 615, 694 
— , gynaecological tumours 
615 
— , neoplasms 694 
, haematological 694 
nephelometry 
- , albumin 614 
— , urine 614 
- , apolipoprotein A 698 
- , apolipoproteins 874 
- , drugs 648 
- , laser 221, 1125, 1213 
— , fibronectin 221, 1213 
— , glycosaminoglycans 221 
— , rheumatoid factor 648, 
1125 
—, methodology 844 
—, proteins 650 
- , transferrin 686 
nephrotoxicity 
- , drugs 682 
— , proteinuria 682 
netilmicin 
—, enzyme immunoassay 873 
- , plasma 656 
— , monitoring 656 
neuraminidase 
- , lymphocytes 857 
neural tube defects 584 
- , tests 879 
neuroblastoma 479 
neuroleptics 
—, clinical chemical effects 
751 
neurotransmitters 
- , HPLC 813 
newborns 
- , dyslipidaemia 615 
— , screening 615 
—, proteinuria 772 
—, urine 787 
— , carcinoembryonic anti-
gen 787 
— , a-foetoprotein 787 
— , Tennessee antigen 787 
— , tissue polypeptide anti-
gen 787 
nickel 
- , proton-induced X-ray 
emission 887 
/?-nitrophenylmaltosides 
- , amylase 634, 645 
nomenclature 
—, tetrapyrroles 43 
noradrenaline 
—, metabolism 987 
- - , rat brain 987 
, and nembutal 987 
—, metabolites 987 
— , estimation 987 
—, serum 323 
— , circadian rhythms 323 
—, urine 323 
— , circadian rhythms 323 
norepinephrine 234 
- , plasma 
normal distribution 1145 
- , inadequacy 1145 




RNase assay 773 
nucleosides 
—, modified 639 
— , HPLC 639 
nucleotides 





- , liver cancer 707 
nutrition 
—, enzyme pattern 829 
— , rat 829 
obesity 
—, metabolites 695 
— , serum 695 
odds 677 
oestradiol 
- , plasma 665 
- , receptors 713, 844 
— , assay 844 
—, urine 73 
oestriol 
—, plasma 800 
— , pregnancy 800 
, diabetics 800 
- , pregnancy 804 
- , serum 803 
— , pregnancy 803 
- , urine 73 
oestrogen(s) 
- , cellular immune reactions 
694 
- , conjugates 781 
— , radioimmunoassay 781 
- , receptor(s) 688, 822, 865 
— , assay 805 
— , breast cancer 609, 688 
— , breast tumour 822 
— , control material 758 
— , histochemistry 749 
— , myometrium 688 
— , rat pituitary 845 
— , standard 865 
- , serum 809 
— , menstrual cycle 809 
- , urine 833, 875 
— , pregnancy 833 
— , quality control 875 
oestrone 
—, electrokinetic studies 810 
oestrone-3-glucuronide 
- , enzyme immunoassay 824 
OLLI CD 229, 749 
- , evaluation 229, 1027 
ORG 2058 801 
organic acids 
- , HPLC 625 
- , profiling 224 
- , serum 654 
ornithine 
- , plasma 1194 
L-ornithine 2-oxoglutarate 
aminotransferase 
- , determination 222 
output control 585 
ovary 
- , cancer 815, 840 
— , isoamylases 815 
— , serum enzymes 840 
- , function 812 
— , progesterone 812 
, saliva 812 
—, perfusates 756 
— , 3,17-androstanediols 
756 
oxalate 
- , calcium 295 
— , crystal growth 295 
, inhibition 295 
- , plasma 815 
oxalate 
- , plasma 
— , chemiluminescence assay 
815 
- , serum 1103 
— , determination 1103 
, oxalate oxidase 1103 
- , urine 630 
- - , gout 630 
- , urolithiasis 713, 714 
oxamniquine 729 
2-oxo-5-guanidinovaleric acid 
—, urine 61, 65 
— , gas chromatography 61 
— , mass spectrometry 61 
— , thin layer chromato-
graphy 61 
5-oxoproline 
—, homocystinuria 851 
oxosteroids 
- , HPLC 727 
oxygen 
- , radical scavenger 766 
— , ^-penicillamine 766 
- , saturation 521 
— , haemoglobin 521 
, and glycerate 2,3-
bisphosphate 521 
oxyhaemoglobin 
- , determination 457 
— , multi-wavelength 
spectrometry 457 
—, dissociation 903 
oxypurines 
- , urine 598 
- - , gout 598 
oxytocinase 145 
PH 
—, measurement 491 
— , history 491 
palmar fascia 
—, enzyme activities 931 
pancreas 
- , diseases 816 
— , trypsinogen 816 
—, enzymes 1181 
- , function 745 
— , fluorescein dilaurate test 
745 
—, ribonuclease 774 
pancreatic secretory trypsin 
inhibitor 
—, serum 737 
— , pancreatitis 737 
pancreatitis 
- , amylase 815, 847 
— , isoenzymes 815, 847 
—, colipase 720 
—, methaemoglobin 847 
—, pancreatic secretory trypsin 
inhibitor 737 
— , serum 737 
—, trypsin 737 
— , serum 737 
paracetamol 
—, assay 806 
— , enzymatic 806 
—, poisoning 705 
PARALLEL analyser 759 
—, system 230 
pattern recognition techniques 
713 
D-penicillamine 




- , inhibitors 953 
— , of penicillinase 953 
- , mercaptides 953 
— , with p-chloromercuri-
benzoate 953 




- , cancer associated 705 
peptide hormones 
- , HPLC 832 
peptide substrates 





- , intestine 265 
— , measurement 265 
peroxidase 
- . horseradish 435 
— , determination 435 
, chromogens 435 
- , Potentiometrie assay 838 
peroxidation 
- , lipids 608 
peroxide 
—, metabolism 608 




luminescence 581, 582 
phalloidin 
liver injury 680 
pharmaceuticals 
- , assay 659 
pharmacokinetics 
- , Cortisol 659 
glucocorticoids 659 
- , methotrexate 882 
phenobarbital 
- , gas chromatography 305 
—, protein binding 716 
- , serum 249 
— , enzyme immunoassay 
249 
— , gas chromatography 249 
phenobarbitone 
- , and y-glutamyltransferase 
632 
— , liver 632 
, Guinea pig 632 
phenothiazines 
- , assay 808 
- , effects 754 
phenylalanine 
- , plasma 1194 
phenylketonuria 228 
- , carriers 
— , frequency 
Phenytoin 
- , gas chromatography 305 
- , saliva 707 
— , composition 707 
- , serum 249 
— , enzyme immunoassay 
249 
— , gas chromatography 249 
phosphatase 
- , acid 351, 590, 626, 706, 
718, 824, 835, 850, 866. 
884 
phosphatase 
- , acid 
— , assay 706 
— , control material 824 
, stability 824 
— , control samples 351 
— , isoenzymes 835 
— , prostate 590, 718, 835 
, enzyme immunoassay 
590 
- - , prostatic 850, 866 
, radioimmunoassay 
866 
, tumour marker 850 
— , rheumatoid arthritis 884 
— , seminal fluid 626 
, infertility 626 
- , alkaline 242, 594, 596, 
625, 707, 748, 800, 833, 
849, 885, 1132, 1181 
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